61,838 Shares in CVS Health Co. (NYSE:CVS) Bought by B. Metzler seel. Sohn & Co. Holding AG

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of CVS Health Co. (NYSE:CVS) during the 3rd quarter, Holdings Channel reports. The firm acquired 61,838 shares of the pharmacy operator’s stock, valued at approximately $3,888,000.

Several other large investors also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter valued at about $31,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health during the third quarter worth about $32,000. First Community Trust NA lifted its position in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the 3rd quarter valued at about $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CVS shares. Truist Financial restated a “buy” rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a report on Wednesday. UBS Group upped their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.28.

CVS Health Stock Performance

Shares of CVS opened at $56.83 on Thursday. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The stock’s 50-day simple moving average is $59.18 and its 200 day simple moving average is $58.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $71.52 billion, a price-to-earnings ratio of 14.42, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the business earned $2.21 earnings per share. CVS Health’s revenue was up 6.3% compared to the same quarter last year. Research analysts forecast that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.68%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.